Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Market Closed
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Other Current Assets
|
Sonoma Pharmaceuticals Inc
Other Current Assets Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Other Current Assets
$4.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
24%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Current Assets
$4.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Current Assets
$2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Current Assets
$5.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Current Assets
$7.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Current Assets
$6.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
See Also
What is Sonoma Pharmaceuticals Inc's Other Current Assets?
Other Current Assets
4.3m
USD
4.3m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Other Current Assets amounts to 4.3m USD.
What is Sonoma Pharmaceuticals Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
24%
24%
Over the last year, the Other Current Assets growth was 24%. The average annual Other Current Assets growth rates for Sonoma Pharmaceuticals Inc have been 9% over the past three years , 20% over the past five years , and 24% over the past ten years .
You don't have any saved screeners yet
